IMMUNOMODULATING AGENT, administration of, by intravenous infusion for at least 2 hours duration - payable once only on the same day and where the agent is provided under section 100 of the Pharmaceutical Benefits Scheme
IMMUNOMODULATING AGENT, administration of, by intravenous infusion for at least 2 hours duration - payable once only on the same day and where the agent is provided under section 100 of the Pharmaceutical Benefits Scheme
| Release | Change | Old | New |
|---|---|---|---|
| July 2026 | Fee ↑ | $114.3 | $117.25 |
Data sourced from Australian Government publications · Not an official government service